Benefit of adjuvant trastuzumab in breast cancer patients with focal HER2 amplified clones: Data from N9831 Intergroup Adjuvant Trial
- Citation:
- J Clin Oncol vol 27 (15) abst 520
- Meeting Instance:
- ASCO 2009
- Year:
- 2009
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 162
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- W. R. Sukov D. V. Miller A. C. Dueck K. S. Tenner R. B. Jenkins P. A. Kaufman N. E. Davidson S. R. Dakhil S. Martino V. Roy E. A. Perez
- Networks:
- Study
- NCCTG-N9831
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: